Concerning the soluble activators of FZD, previous studies have shown the common downregulation of sFRP1 due to promoter hypermethylation in HCC as well as in colon cancer (Suzuki et al, 2004; Shih et al, 2006, 2007). This evidence concerns the gene SFRP1 and colonic neoplasm.